Helicobacter Pylori Eradication With a New Sequential Treatment
Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
Eradication rates of Helicobacter pylori (H. pylori) with standard triple therapy are
disappointing, and studies from several countries confirm this poor performance. The study
aimed to assess the eradication rate of a new sequential treatment regimen compared with
conventional triple therapy for the eradication of H. pylori infection.
Phase:
Phase 3
Details
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna St. Orsola Hospital